Provision of Palliative Combined Pembrolizumab-Chemotherapy in Head and Neck Cancer in England: Time for a Review of the Evidence.

Kelly, C; Barnett, G; Iqbal, M S

Kelly, C; Barnett, G; Iqbal, M S.

Afiliação

Kelly C; Northern Centre for Cancer Care, Freeman Hospital, The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, NE7 7DN, United Kingdom. Electronic address: Charles.kelly1@nhs.net.
Barnett G; Cambridge University Hospital NHS Foundation Trust, Hills Rd, Cambridge CB2 0QQ, United Kingdom. Electronic address: gill.barnett1@nhs.net.
Iqbal MS; Newcastle University, Northern Centre for Cancer Care, Freeman Hospital, The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, NE7 7DN, United Kingdom. Electronic address: shahid.iqbal@nhs.net.

Clin Oncol (R Coll Radiol) ; 2024 May 15.

Article em En | MEDLINE | ID: mdl-38821724

Palavras-chave

Chemotherapy; head and neck cancer; immunotherapy; pembrolizumab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Oncol (R Coll Radiol) Assunto da revista: NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google